2023-02-14
Sona Nanotech Inc. is pleased to announce that it has entered into a binding agreement on January 26, 2023 to acquire Siva Therapeutics, Inc., the developer of Targeted Hyperthermia Therapy™ (THT) photo thermal therapy for cancer tumors using Sona's uniquely biocompatible gold nanorods.
